OPEN HT: a dialogue with the scientific community
Today Monday 19 December from 10.00 a.m. in the Human Technopole Auditorium at MIND Milano Innovation District OPEN HT took place. The event represented an opportunity for dialogue between the life sciences Institute and the national scientific community.
The initiative was also the occasion to share the developments of Human Technopole as detailed in the biennial report (2020-2021) already transmitted to the Houses of Parliament and the Ministries of Economy and Finance, University and Research, and Health) as required by Law 160/2019 paragraph 275. The full report is available at the following link.
The morning included speeches by Foundation President Gianmario Verona, Director Iain Mattaj and the Heads of the five research centres currently active at the institute. The Director General of the Ministry of Health Giovanni Leonardi was also present via remote connection.
Human Technopole has been operational since January 2019, with the arrival of the first Director Iain Mattaj. In October 2019, the first Heads of Research Centre joined the institute and the initial core of administrative staff.
In May 2020, Human Technopole was given the task of creating a Centre for Innovation and Technology Transfer (CITT) with the aim of helping to promote a wider exploitation of the results of research and technological innovation in the Italian life sciences sector.
In December 2020, an agreement was signed between Human Technopole and its founding ministries (Economy and Finance, University and Research, and Health) governing the identification of National Facilities (NF) with a high technological impact to be set up at HT. These facilities will be accessible to the national and international scientific community to conduct high quality research in their respective fields.
In 2021, the first research laboratories were opened. After thorough re-functionalisation, the campus currently occupies an area of approximately 30,000 square metres and consists of three existing buildings (Palazzo Italia, North Pavilion, South Pavilion) and the newly constructed incubator labs, totalling 25,000 square metres of interdisciplinary laboratories. A new building – the South Building – will be constructed in the coming years. Once completed, the Campus will also house the National Facilities envisaged by the additional activities entrusted to the Institute by Law 160/2019.
Today, Human Technopole employs more than 340 people, including 220 researchers and scientific support staff. These are professionals of 30 different nationalities, with an average age of 36. The institute’s researchers have already received EUR 8.7 million in external funding through grants and fellowships from European and international institutes.
When fully operational, Human Technopole will employ up to 1,000 scientists in various fields including biology, bioinformatics, chemistry, engineering, physics, mathematics, computational studies and computer science who will work together on research topics of biomedical relevance.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.